Financial News Feed

If you want to know who really controls Aptose Biosciences Inc. (TSE:APS), then you'll have to look at the makeup of…...

Read more

No summary available....

Read more

PVH, JILL and PANW among premarket losers
01:11pm, Thursday, 30'th May 2019
No summary available....

Read more

No summary available....

Read more

Aptose Biosciences beats by $0.03
08:03pm, Tuesday, 07'th May 2019
Aptose Biosciences (APTO): Q1 GAAP EPS of -$0.14 beats by $0.03. Press Release...

Read more

No summary available....

Read more

No summary available....

Read more

Checking in on shares of Aptose Bioscns (APTO), we can see that the current opinion signal on the stock for today’s session is 16% Sell. Looking back at the last month, the opinion signal reads 96% ...

Read more

Both Harpoon Therapeutics Inc. (NASDAQ:HARP) and Aptose Biosciences Inc. (NASDAQ:APTO) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regards t...

Read more

Aptose Biosciences Inc. (NASDAQ:APTO) (TSE:APS) – Research analysts at Oppenheimer lowered their FY2021 earnings per share estimates for shares of Aptose Biosciences in a research note issued to inv...

Read more

Tracking recent technical action on shares of Aptose Bioscns (APTO), we have identified that Span A is now above Span B. Following these signals, traders may be watching to see if the stock is poised ...

Read more

Both Aptose Biosciences Inc. (NASDAQ:APTO) and Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) are Biotechnology companies, competing one another. We will contrast their dividends, institutional ownershi...

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank